The COVID-19 Pandemic – Products

Carterra, Inc. and La Jolla Institute for Immunology (LJI) announced today that LJI has acquired a Carterra LSA instrument to enhance its antibody screening and characterization work.

AMSBIO offers a range of lentivirus production services to provide tailor-made products to support your research.

Thermo Fisher Scientific Inc. is showcasing innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics.

Seegene Inc. will work with test center, LabHouse, to launch its In-life PCR campaign in Vietnam, for drivers of ride-hailing service Grab, starting August.

Quest Diagnostics has announced the nationwide availability of the company's lab-developed molecular diagnostic test to aid in the diagnosis of infection with the monkeypox virus, with plans to launch the CDC's orthopoxvirus test in the first half of August.

Vaccizone has selected Exothera S.A. to fast-track process development of its SARS-CoV-2 vaccine for European clinical trials.

Seegene Inc. has obtained EU approval for its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay that is compatible with the company’s fully automated AIOS.

A new laboratory automation platform has been demonstrated to facilitate the running of complex scientific experiments in laboratories operating under COVID-19 constraints such as social distancing and stay-at-home orders.

Matrix Diagnostics, a dedicated COVID-19 testing lab in California, is relying on INTEGRA Biosciences’ EVOLVE and MINI 96 pipettes to streamline and accelerate its PCR workflows.

Brain-computer interface (BCI) trials may soon be more accessible to a greater population of candidates living with paralysis, per a new partnership agreement between Blackrock Neurotech, a leader in implantable brain technology, and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL).